Get the Stockscreener App
6.64
0.15%
0.010
After Hours:
6.64
Lifeward Ltd stock is traded at $6.64, with a volume of 4,918.
It is up +0.15% in the last 24 hours and down -3.07% over the past month.
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.
See More
Previous Close:
$6.63
Open:
$6.6
24h Volume:
4,918
Relative Volume:
0.21
Market Cap:
$25.13M
Revenue:
$22.03M
Net Income/Loss:
$-19.91M
P/E Ratio:
-0.3587
EPS:
-18.5136
Net Cash Flow:
$-16.84M
1W Performance:
+2.79%
1M Performance:
-3.07%
6M Performance:
-27.28%
1Y Performance:
-61.03%
1-Day Range:
$6.2514
$6.64
1-Week Range:
$6.11
$6.67
52-Week Range:
$4.14
$18.60
Lifeward Ltd Stock (LFWD) Company Profile
Name
Lifeward Ltd
Sector
Industry
Phone
15082511154
Address
200 DONALD LYNCH BLVD., MARLBOROUGH
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
6.64 | 25.09M | 22.03M | -19.91M | -16.84M | -18.51 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-25 | Initiated | Laidlaw | Buy |
| Apr-03-17 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-16-16 | Initiated | Oppenheimer | Outperform |
| Jul-15-16 | Initiated | Piper Jaffray | Overweight |
| May-22-15 | Upgrade | Canaccord Genuity | Hold → Buy |
| May-08-15 | Reiterated | Barclays | Equal Weight |
| Oct-07-14 | Initiated | Barclays | Equal Weight |
View All
Lifeward Ltd Stock (LFWD) Latest News
Lifeward (LFWD) director receives 11,485 RSUs vesting over four quarters - Stock Titan
Lifeward Ltd. (LFWD) director submits Form 3 with no insider trades - Stock Titan
Lifeward (LFWD) awards 11,485 RSUs to company director - Stock Titan
Lifeward (LFWD) director Moshe H Rozenbaum files initial Form 3 - Stock Titan
Returns Recap: Can Lifeward Ltd be recession proofPortfolio Risk Summary & Low Risk Investment Opportunities - baoquankhu1.vn
Recap Report: Is Lifeward Ltd a turnaround storyWeekly Trade Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Aug PreEarnings: Is Lifeward Ltd a good stock for dollar cost averaging2026 Reactions & Reliable Volume Spike Alerts - baoquankhu1.vn
Lifeward stock plummets on pricing of $2.6M public offering - MSN
Aug Setups: Why is Lifeward Ltd stock going upMarket Trend Report & High Accuracy Trade Alerts - baoquankhu1.vn
Lifeward scoops US$20M after completing Oratech Pharma takeover - Mugglehead Investment Magazine
Sell Signal: Does Lifeward Ltd offer margin of safety2026 Risk Factors & Technical Buy Zone Confirmation - baoquankhu1.vn
Big Picture: Will Lifeward Ltd benefit from government policyForecast Cut & Advanced Technical Signal Analysis - baoquankhu1.vn
S P Trends: Is Lifeward Ltd stock heavily shorted2026 Update & Safe Capital Investment Plans - baoquankhu1.vn
LFWD Earnings History & Surprises | EPS & Revenue Results | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill
Oramed Completes Oratech Sale and Strategic Lifeward Financing - The Globe and Mail
Lifeward Restores Nasdaq Compliance With Audit Committee Changes - The Globe and Mail
Oramed (ORMP) completes Oratech sale and buys $9M Lifeward notes - Stock Titan
Lifeward Ltd. 8-K SEC Filing March 2026: Company Information, NASDAQ Listing, and Entity Details - Minichart
Lifeward regains Nasdaq compliance after audit committee appointments By Investing.com - Investing.com South Africa
Lifeward regains Nasdaq compliance after audit committee appointments - investing.com
Lifeward regains Nasdaq audit committee compliance after new appointments - TradingView — Track All Markets
Lifeward (NASDAQ: LFWD) regains Nasdaq audit committee compliance after board change - Stock Titan
LFWD SEC FilingsLifeward Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Dow Update: Will Lifeward Ltd outperform small cap indexesMarket Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Lifeward shares fall after Q4 results miss expectations - MSN
Lifeward (LFWD) price target increased by 344.44% to 20.40 - MSN
Lifeward (NASDAQ: LFWD) grants CFO options on 39,934 shares - stocktitan.net
Lifeward (LFWD) CEO awarded 172,698 options at $6.53 strike - Stock Titan
Director at Lifeward (LFWD) granted 7,657 RSUs vesting quarterly - stocktitan.net
Lifeward (LFWD) director receives 7,657 RSU grant under 2025 plan - stocktitan.net
Director Miriam Kidron receives 7,657-share RSU grant at Lifeward (NASDAQ: LFWD) - Stock Titan
Lifeward (LFWD) director Reznick Yehuda files initial insider Form 3 - Stock Titan
Lifeward (LFWD) director Nadav Kidron submits initial Form 3 ownership - stocktitan.net
Lifeward (LFWD) director Miriam Kidron submits initial Form 3 insider report - stocktitan.net
Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - Stock Titan
Lifeward Completes Oratech Acquisition and Secures Private Financing - The Globe and Mail
Lifeward (LFWD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga France
Aug Spikes: Is Lifeward Ltd in a long term uptrend2026 Levels & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Lifeward closes Oramed partnership, secures $10 million funding By Investing.com - Investing.com Australia
Lifeward Ltd. 8-K Filing: Share Purchase Agreement Assignment to Oratech Ltd. and Entity Information (March 2026) - Minichart
Lifeward Closes Oramed Partnership, Acquires Oratech Pharma - Moomoo
Lifeward closes Oramed partnership, secures $10 million funding - Investing.com
Lifeward (NASDAQ: LFWD) closes Oratech buy with new shares and $10M notes - Stock Titan
Lifeward adds biotech drug-delivery tech and taps up to $47M - stocktitan.net
Insider Sell: Is Lifeward Ltd affected by consumer sentiment2026 Decliners & Target Return Focused Stock Picks - baoquankhu1.vn
Lifeward Successfully Closes on Strategic Partnership with Oramed - Bitget
Lifeward Ltd. completed the acquisition of Oratech Pharma, Inc. from Oramed Pharmaceuticals Inc.. - marketscreener.com
If You Invested $1,000 in Lifeward Ltd (LFWD) - Stock Titan
Lifeward Faces Nasdaq Audit Committee Compliance Challenge - The Globe and Mail
Aug Levels: Is Lifeward Ltd a speculative investmentQuarterly Market Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Lifeward Ltd. Files Form 8-K with SEC – Key Company Information and Filing Details for March 2026 - Minichart
Lifeward Ltd Stock (LFWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lifeward Ltd Stock (LFWD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jasinski Lawrence J | Chief Executive Officer |
May 21 '25 |
Sale |
1.26 |
1,909 |
2,405 |
98,728 |
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):